{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:15Z","timestamp":1787010135692,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Ex vivo<\/jats:italic>\n                    hemocompatibility testing is a vital element of preclinical assessment for blood-contacting medical devices. Current approaches are resource intensive; thus, we investigated the feasibility of accelerating hemocompatibility testing by standardizing the number of pump exposures in loops of various sizes. Three identical blood loops were constructed, each with a custom-molded reservoir able to facilitate large-volume expansion. Using the HVAD rotary blood pump operating at 5 L\u00b7min\n                    <jats:sup>\u22121<\/jats:sup>\n                    and 100 mmHg, three test volumes (80, 160, and 320\u2009ml) were circulated for 4000 pump exposures. Blood sampling was performed at individualized intervals every one-sixth of total duration for the assessment of hemolysis and von Willebrand Factor (vWF) degradation. While steady increases in hemolysis (~24 mg\u00b7dl\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) were identified in all tests at completion, loop volume was not a primary discriminator. The normalized index of hemolysis did not vary significantly between loops (4.2\u20134.9 mg\u00b7100\u2009L\n                    <jats:sup>\u22121<\/jats:sup>\n                    ). vWF degradation progressively occurred with duration of testing to a similar extent under all conditions. These data support an accelerated approach to preclinical assessment of\n                    <jats:italic toggle=\"yes\">ex vivo<\/jats:italic>\n                    blood damage. Adopting this approach enables: enhanced efficiency for rapid prototyping; reduced ex vivo blood aging, and; greater utility of blood, which is presently limited if 450\u2009ml loops are desired.\n                  <\/jats:p>","DOI":"10.1097\/mat.0000000000001995","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T13:47:24Z","timestamp":1685540844000},"page":"918-923","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Accelerated Hemocompatibility Testing of Rotary Blood Pumps"],"prefix":"10.1097","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-487X","authenticated-orcid":false,"given":"Antony P.","family":"McNamee","sequence":"first","affiliation":[{"name":"From the Biorheology Research Laboratory, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia A.","family":"Griffith","sequence":"additional","affiliation":[{"name":"From the Biorheology Research Laboratory, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda G.","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Biorheology Research Laboratory, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Kuck","sequence":"additional","affiliation":[{"name":"From the Biorheology Research Laboratory, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Simmonds","sequence":"additional","affiliation":[{"name":"From the Biorheology Research Laboratory, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"R2-20250530","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.","volume":"36","author":"Kirklin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250530","first-page":"215","article-title":"FDA: Stop using Medtronic\u2019s Heartware ventricular assist device.","volume":"326","author":"Kuehn","year":"2021","journal-title":"JAMA"},{"key":"R5-20250530","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/03913988221095581","article-title":"Bovine erythrocytes are poor surrogates for human when exposed to sublethal shear stress.","volume":"45","author":"McNamee","year":"2022","journal-title":"Int J Artif Organs"},{"key":"R6-20250530","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1007\/s10439-021-02849-1","article-title":"Validation of a miniaturized test loop for the assessment of human blood damage by continuous-flow left-ventricular assist devices.","volume":"49","author":"Woelke","year":"2021","journal-title":"Ann Biomed Eng"},{"key":"R7-20250530","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10439-019-02404-z","article-title":"Miniaturized test loop for the assessment of blood damage by continuous-flow left-ventricular assist devices.","volume":"48","author":"Woelke","year":"2020","journal-title":"Ann Biomed Eng"},{"key":"R9-20250530","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/00365515909060410","article-title":"A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry.","volume":"11","author":"Harboe","year":"1959","journal-title":"Scand J Clin Lab Invest"},{"key":"R10-20250530","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/aor.13471","article-title":"Evaluation of in vitro hemolysis and platelet activation of a newly developed maglev LVAD and two clinically used LVADs with human blood.","volume":"43","author":"Berk","year":"2019","journal-title":"Artif Organs"},{"key":"R11-20250530","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cardfail.2019.09.013","article-title":"In vitro benchmarking study of ventricular assist devices in current clinical use.","volume":"26","author":"Radley","year":"2020","journal-title":"J Card Fail"},{"key":"R12-20250530","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1111\/aor.13877","article-title":"Ex vivo assessment of erythrocyte tolerance to the HeartWare ventricular assist device operated in three discrete configurations.","volume":"45","author":"Kuck","year":"2021","journal-title":"Artif Organs"},{"key":"R13-20250530","first-page":"171","article-title":"Erythrocyte deformability responses to intermittent and continuous subhemolytic shear stress.","volume":"51","author":"Simmonds","year":"2014","journal-title":"Biorheology"},{"key":"R14-20250530","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0006-3495(79)85238-8","article-title":"Red cell extensional recovery and the determination of membrane viscosity.","volume":"26","author":"Hochmuth","year":"1979","journal-title":"Biophys J"},{"key":"R15-20250530","doi-asserted-by":"crossref","first-page":"e12652","DOI":"10.1111\/micc.12652","article-title":"Sublethal mechanical shear stress increases the elastic shear modulus of red blood cells but does not change capillary transit velocity.","volume":"27","author":"McNamee","year":"2020","journal-title":"Microcirculation"},{"key":"R16-20250530","first-page":"73","article-title":"Alteration of red cell membrane viscoelasticity by heat treatment: effect on cell deformability and suspension viscosity.","volume":"22","author":"Nash","year":"1985","journal-title":"Biorheology"},{"key":"R17-20250530","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/aor.12997","article-title":"Oxidative stress increases erythrocyte sensitivity to shear-mediated damage.","volume":"42","author":"McNamee","year":"2018","journal-title":"Artif Organs"},{"key":"R18-20250530","first-page":"141","article-title":"Recovery time course of erythrocyte deformability following exposure to shear is dependent upon conditioning shear stress.","volume":"54","author":"Kuck","year":"2018","journal-title":"Biorheology"},{"key":"R19-20250530","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1111\/trf.16086","article-title":"Hemochromatosis alters the sensitivity of red blood cells to mechanical stress.","volume":"60","author":"Richardson","year":"2020","journal-title":"Transfusion"},{"key":"R20-20250530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood.V63.1.73.73","article-title":"Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease.","volume":"63","author":"Nash","year":"1984","journal-title":"Blood"},{"key":"R21-20250530","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V74.2.855.855","article-title":"Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum.","volume":"74","author":"Nash","year":"1989","journal-title":"Blood"},{"key":"R22-20250530","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fphys.2020.00576","article-title":"Mechanical signature of red blood cells flowing out of a microfluidic constriction Is impacted by membrane elasticity, cell surface-to-volume ratio and diseases.","volume":"11","author":"Faivre","year":"2020","journal-title":"Front Physiol"},{"key":"R23-20250530","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device.","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"R24-20250530","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"R25-20250530","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2015.11.002","article-title":"Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.","volume":"137","author":"Jilma-Stohlawetz","year":"2016","journal-title":"Thromb Res"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000001995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:03:32Z","timestamp":1748595812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000001995","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}